How Biodesign technologies help patients
Stanford Biodesign trainees have developed new medical devices and diagnostics that have been used to help care for more than 1.5 million patients so far.
Toward a malaria vaccine for pregnant women
Prasanna Jagannathan said the $100,000 prize will allow his lab team to ramp up their research in Uganda.
New therapy for drug-resistant epilepsy
The FDA has approved the use of an implanted device that releases periodic electrical discharges in the brain to counteract seizures in people with epilepsy. In an interview, neurologist Robert Fisher described the technology and Stanford’s role in testing the device.
Depression, blood levels of substance linked
Investigators at Stanford and elsewhere have shown, for the first time in humans, that low blood levels of acetyl-L-carnitine track with the severity and duration of depression.
Genetic screen predicts osteoporosis risk
A new genetic screen may be able to predict low bone-mineral density, osteoporosis and fracture risk prior to clinical symptoms, according to a retrospective study of nearly 400,000 people by a Stanford researcher.